Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: |
Title | Novel Oncology Drugs, Devices and Molecular Diagnostics - Sayre |
Description | About At Sayre Therapeutics, we focus on bringing hitherto unavailable novel medicines, drug-delivery devices, companion diagnostics and diagnostic imaging agents to medical oncologists, surgical oncologists, radiation oncologists, interventional |
Keywords | N/A |
WebSite | sayretherapeutics.com |
Host IP | 43.255.154.47 |
Location | Singapore |
Site | Rank |
US$872,184
Last updated: 2023-05-09 12:23:50
sayretherapeutics.com has Semrush global rank of 12,135,408. sayretherapeutics.com has an estimated worth of US$ 872,184, based on its estimated Ads revenue. sayretherapeutics.com receives approximately 100,637 unique visitors each day. Its web server is located in Singapore, with IP address 43.255.154.47. According to SiteAdvisor, sayretherapeutics.com is safe to visit. |
Purchase/Sale Value | US$872,184 |
Daily Ads Revenue | US$806 |
Monthly Ads Revenue | US$24,153 |
Yearly Ads Revenue | US$289,834 |
Daily Unique Visitors | 6,710 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
sayretherapeutics.com. | A | 10794 | IP: 43.255.154.47 |
sayretherapeutics.com. | NS | 3600 | NS Record: ns20.domaincontrol.com. |
sayretherapeutics.com. | NS | 3600 | NS Record: ns19.domaincontrol.com. |
sayretherapeutics.com. | MX | 3600 | MX Record: 0 sayretherapeutics-com.mail.protection.outlook.com. |
sayretherapeutics.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com include:spf.mandrillapp.com -all |
sayretherapeutics.com. | TXT | 3600 | TXT Record: google-site-verification=57rlgbYdfz1_s4cjhEYvqnqJZhaFgUYN8Rj0kBSeEnU |
sayretherapeutics.com. | TXT | 3600 | TXT Record: MS=ms88964095 |
sayretherapeutics.com. | TXT | 3600 | TXT Record: v=DMARC1; p=quarantine; rua=mailto:rajesh.sasidharan@sayretherapeutics.com |
Email LinkedIn Twitter Search for: Home About Vision & Mission People CSR Portfolio Oncology Drugs Globally Approved Novels DC Bead Lutrate Lymphoaim DaunoXome Biosimilars RasCase PegNustim MejorAsp Niche Generics UTEGCIL Solfredoc RTU OCTRI-LAR CAVEOLIN-PTX CelstemX CLADTRIOS Molecular Diagnostics TEMPUS Color BGI Order a Test Here Alacris CUP Special Access Programs Dinutuximab- BETA Darinaparsin Eculizumab NERATINIB Carmustine Wafers Transarterial Radioembolization (TARE) 5-ALA Electric Field Therapy Dexrazoxane Interleukin-2 Cesium-131 seeds Immunology Drug PENNSAID Novel Drug Delivery Devices Zeneo Alliances Newsroom Press Blogs Careers Contact Us Accelerated introduction of healthcare innovations to South Asia Committed to improving outcomes for cancer patients Precision diagnostic solutions Learn More Order Test Version 2 admin 2022-10-11T13:40:51+00:00 About US Sayre Therapeutics was founded in 2015 backed by leading global Venture Capital (VC) firms. The team boasts 25 years |
Domain Name: SAYRETHERAPEUTICS.COM Registry Domain ID: 1901087002_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-01-07T11:44:11Z Creation Date: 2015-02-06T07:09:57Z Registry Expiry Date: 2023-02-06T07:09:57Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS19.DOMAINCONTROL.COM Name Server: NS20.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-19T06:25:04Z <<< |